The upcoming APCCC 2019 meeting on advanced prostate cancer

The first iteration of the Advanced Prostate Cancer Consensus Conference (APCCC) was held in St. Gallen, Switzerland, in 2017, and the second iteration is upcoming in late August this year — this time in Basel. … READ MORE …

Report from APCCC 2017 on management of advanced prostate cancer

For those who really want all the details, the full text of the report from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017 is now available on line. … READ MORE …

Finding common ground on how “best” to treat localized prostate cancer, and what to tell the patients

One of the hardest issues for newly diagnosed prostate cancer patients to deal with has long been the differences in opinion between physicians about appropriate first-line treatment (and the relevant information they are offered) — most especially for patients with localized disease. … READ MORE …

St. Gallen consensus conference on treatment of advanced prostate cancer

Apparently, early in 2015, there was a major international consensus conference, among nearly 50 of the leading international authorities, on the treatment of advanced prostate cancer. … READ MORE …

Consensus statement on pathologic factors and active surveillance

As previously mentioned earlier this week, a long statement that deals with the role of the pathologist in determining the suitability of patients for enrollment into active surveillance management protocols has been issued and endorsed by a number of organizations. … READ MORE …

Increasing consensus on eligibility criteria for active surveillance

A paper in the journal Virchows Archiv suggests increasing consensus on both inclusion criteria for management on active surveillance and progression criteria suggesting the need for active treatment. … READ MORE …

Prostate Cancer Roundtable endorses statement on early detection in men at high risk

The Prostate Cancer Roundtable has endorsed a statement developed by the Prostate Health Education Network (PHEN) on the role of PSA testing in the early detection of prostate cancer among men acknowledged to be at elevated risk. … READ MORE …